Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database

  1. Wolff, I.
  2. May, M.
  3. Hoschke, B.
  4. Zigeuner, R.
  5. Cindolo, L.
  6. Hutterer, G.
  7. Schips, L.
  8. De Cobelli, O.
  9. Rocco, B.
  10. De Nunzio, C.
  11. Tubaro, A.
  12. Coman, I.
  13. Feciche, B.
  14. Truss, M.
  15. Dalpiaz, O.
  16. Figenshau, R.S.
  17. Madison, K.
  18. Sánchez-Chapado, M.
  19. Santiago Martin, M.D.C.
  20. Salzano, L.
  21. Lotrecchiano, G.
  22. Shariat, S.F.
  23. Hohenfellner, M.
  24. Waidelich, R.
  25. Stief, C.
  26. Miller, K.
  27. Pahernik, S.
  28. Brookman-May, S.
  29. Show all authors +
Journal:
European Journal of Surgical Oncology

ISSN: 1532-2157 0748-7983

Year of publication: 2016

Volume: 42

Issue: 5

Pages: 744-750

Type: Article

DOI: 10.1016/J.EJSO.2016.01.009 GOOGLE SCHOLAR